Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension

NCT01413048 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Carvedilol 25mg
DRUG: AGSCT101 12.5mg

Sponsor

Ahn-Gook Pharmaceuticals Co.,Ltd